[go: up one dir, main page]

ATE462476T1 - Verbesserte formulierung für hautbleichmittel - Google Patents

Verbesserte formulierung für hautbleichmittel

Info

Publication number
ATE462476T1
ATE462476T1 AT04704302T AT04704302T ATE462476T1 AT E462476 T1 ATE462476 T1 AT E462476T1 AT 04704302 T AT04704302 T AT 04704302T AT 04704302 T AT04704302 T AT 04704302T AT E462476 T1 ATE462476 T1 AT E462476T1
Authority
AT
Austria
Prior art keywords
skin
improved skin
skin bleaching
bleaching formulation
formulation
Prior art date
Application number
AT04704302T
Other languages
English (en)
Inventor
Xina Nair
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE462476T1 publication Critical patent/ATE462476T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04704302T 2003-02-03 2004-01-22 Verbesserte formulierung für hautbleichmittel ATE462476T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44449603P 2003-02-03 2003-02-03
PCT/IB2004/000240 WO2004069221A1 (en) 2003-02-03 2004-01-22 Improved formulation for skin-lightening agents

Publications (1)

Publication Number Publication Date
ATE462476T1 true ATE462476T1 (de) 2010-04-15

Family

ID=32850872

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04704302T ATE462476T1 (de) 2003-02-03 2004-01-22 Verbesserte formulierung für hautbleichmittel

Country Status (9)

Country Link
US (1) US20060257340A1 (de)
EP (1) EP1592397B1 (de)
JP (1) JP2006516605A (de)
AT (1) ATE462476T1 (de)
BR (1) BRPI0407193A (de)
CA (1) CA2513949A1 (de)
DE (1) DE602004026272D1 (de)
MX (1) MXPA05008243A (de)
WO (1) WO2004069221A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060210498A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
US20060210497A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives
FR2930145B1 (fr) * 2008-04-16 2012-08-03 Fabre Pierre Dermo Cosmetique Utilisation d'un extrait de myrte comme depigmentant.
US8496917B2 (en) * 2009-11-13 2013-07-30 Sytheon Ltd Compositions and methods for improving skin appearance
GB0922200D0 (en) * 2009-12-21 2010-02-03 Xyrex Ltd Composition, use and method of preparation thereof
BR112012029959B1 (pt) * 2010-05-25 2018-01-23 Symrise Ag Compostos de carbamato de mentila, seus usos, composições e métodos cosméticos para clareamento da pele e/ou cabelo
US20130011347A1 (en) * 2011-07-07 2013-01-10 Paul Robert Tanner Personal Care Compositions With Improved Solubility of a Solid Cosmetic Active
CA3167320A1 (en) 2013-03-08 2014-09-12 Unilever Global Ip Limited Resorcinol compounds for dermatological use
FR3045604B1 (fr) * 2015-12-18 2018-01-26 L'oreal Procede de depigmentation des matieres keratiniques a l'aide de composes thiopyridinones
JP7369991B2 (ja) 2019-05-11 2023-10-27 国立大学法人東海国立大学機構 ヘアレスPofut1ヘテロ接合型ノックアウトマウス、Dowling-Degos病治療用化合物のスクリーニング方法、および、Dowling-Degos病治療用医薬組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711904A (en) * 1986-08-04 1987-12-08 Luzzi Louis A Method of treating skin disorders
SK43294A3 (en) * 1991-10-16 1995-01-12 Richardson Vicks Inc Agent improving the penetration of treatments at surface application
US5833998A (en) * 1995-11-06 1998-11-10 The Procter & Gamble Company Topical compositions for regulating the oily/shiny appearance of skin
US5824326A (en) * 1997-06-27 1998-10-20 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Activity enhancement of ferulic acid with dimethyl isosorbride in cosmetic compositions
BR9803596A (pt) * 1997-09-23 2000-04-25 Pfizer Prod Inc Derivados do resorcinol.
US6828460B2 (en) * 1999-03-22 2004-12-07 Pfizer Inc. Resorcinol derivatives
US6878381B2 (en) * 1999-03-22 2005-04-12 Pfizer, Inc Resorcinol composition
US6762158B2 (en) * 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
CN100348166C (zh) * 2002-09-20 2007-11-14 Fmc有限公司 含有微晶纤维素的化妆品组合物
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof

Also Published As

Publication number Publication date
EP1592397B1 (de) 2010-03-31
EP1592397A1 (de) 2005-11-09
DE602004026272D1 (de) 2010-05-12
US20060257340A1 (en) 2006-11-16
BRPI0407193A (pt) 2006-02-14
MXPA05008243A (es) 2005-10-05
WO2004069221A1 (en) 2004-08-19
CA2513949A1 (en) 2004-08-19
JP2006516605A (ja) 2006-07-06

Similar Documents

Publication Publication Date Title
MX353841B (es) Composiciones antimicrobianas y metodos de uso.
CR8428A (es) Agente endoparasiticidas para la administracion topica
PE20142371A1 (es) Combinacion farmaceutica de 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y un antiepileptico
ECSP077299A (es) Nuevas composiciones farmacéuticas que comprenden ácido 4-(4-(3-(4-cloro-3-trifluorometil-fenil)-ureido)-3-fluoro-fenoxi)-piridin-2-carboxílico para el tratamiento de trastornos hiperproliferativos
MX2007002398A (es) Nuevas composiciones farmaceuticas para el tratamiento de cancer.
BR112014000178A2 (pt) composições tópicas
IN2012DN02817A (de)
HK1093678A1 (en) Cosmetic composition containing nicotinamide and self tanning agent for use as self tanning composition
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
EA201001283A1 (ru) Комбинация витамина d и 25-гидроксивитамина d3
RU2008112676A (ru) Противоопухолевое средство
ATE462476T1 (de) Verbesserte formulierung für hautbleichmittel
MY158428A (en) Topical composition for the treatment of actinic keratosis
ATE448777T1 (de) Mittel für die transdermale verabreichung von nikotin
BRPI0920355B8 (pt) composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina
MX2007006539A (es) Sistema para la absorcion percutanea mejorada de los agentes beneficiadores de la piel.
CR7995A (es) Nueva difenilazetidinona con caracteristicas fisiologicas mejoradas correspondiente metodo de produccion , medicamentos que lo contienen y uso de los mismos
BR112012014737A2 (pt) calconas como realçador de agentes antimicrobianos
DE602005001170D1 (de) Kosmetisches Mittel Formulierungskit
UY30451A1 (es) 18-metil-19-nor-androst-4-en-17,17-espiroéteres (18-metil-19-nor-20-espirox-4-en-3-onas),ase como preparaciones farmacéuticas que lo contienen.
WO2007056236A3 (en) Methods of treating cancer with lipid-based platinum compound formulations administered intravenously
GT200600121A (es) Novedosos derivados de triazolopirimidina
BRPI0608287A2 (pt) agente endoparasiticida
AR057648A1 (es) Composicion de metaflumizona para la administracion topica
EP1608395A4 (de) Antikrebsmittel mit lk8-protein als wirkstoff

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties